Protagonist Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Protagonist Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

Protagonist Therapeutics (PTGX) Tops Q4 EPS by 2c, Revenues Miss

March 10, 2020 4:03 PM EDT

Protagonist Therapeutics (NASDAQ: PTGX) reported Q4 EPS of ($0.63), $0.02 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.72 million versus the consensus estimate of $3.22 million.

"We are pleased to have made great progress in 2019, creating multiple opportunities to execute on our clinical... More